Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angvaccine
- Development stage
- Unknown
- Lead developer
- Wuhan Huajiyuan Biotechnology Development
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Angvaccine is a therapeutic vaccine developed by Wuhan Huajiyuan Biological Technology Development for the treatment of hypertension. It is designed to stimulate the patient's immune system to produce specific, long-lasting antibodies against Angiotensin II, a key peptide in the renin-angiotensin system that causes vasoconstriction and increases blood pressure. By neutralizing circulating Angiotensin II, the vaccine aims to reduce peripheral vascular resistance and provide sustained blood pressure control, potentially reducing the need for daily oral antihypertensive medications. The vaccine typically consists of Angiotensin II or a mimic conjugated to a carrier protein to overcome self-tolerance.
- Brand names
- Angvaccine
- Other names
- Angiotensin II therapeutic vaccineAngiotensin II vaccineATII vaccine
Beyond the preview
Go deeper on Angvaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angvaccine.